Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura

Inclusion Criteria: * Aged between 2 and 12 years. * Written informed consent signed by parents/caregivers (signature or thumbprint) and, for children aged 6-12 years, written assent from the child. * Agree to comply with study procedures, including provision of two stool samples at the baseline and at follow-up assessment 14-21 days after treatment, respectively. * At least two out of four Kato-Katz thick smears positive for T. trichiura at baseline. * Willing to be examined by a study physician prior to treatment. Exclusion Criteria: * Presence or signs of major systemic illness or abnormal physical findings at screening, e.g. severe anaemia (Hb level \<80 g/L according to WHO) upon initial clinical assessment. * Known allergy to study medication (i.e. oxantel pamoate, mebendazole or any of the excipients). * Use of anthelminthic drugs within 4 weeks before or during study period. * Being prescribed or taking concomitantly medication with known contraindication or drug interactions with the study medication. * Actively participating in other clinical trials during the study. * Pregnancy (female participants that report to have reached menarche